Schuehle; Martin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schuehle; Martin.The latest application filed is for "aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline".

Company Profile

1.9.9

Schuehle; Martin - Biberach an der Riss DE
Schuehle; Martin - Oberhoefen N/A DE
Schuehle; Martin - Ingelheim am Rhein DE
Schuehle; Martin - Oberhofen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline Grant 9,120,769 - Eckhardt , et al. September 1, 2	2015-09-01
Aryl-and Heteroarylcarbonyl Derivatives Of Hexahydroindenopyridine And Octahydrobenzoquinoline App 20140249174 - Eckhardt; Matthias ; et al.	2014-09-04
Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline Grant 8,686,149 - Eckhardt , et al. April 1, 2	2014-04-01
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 Grant 8,680,093 - Renz , et al. March 25, 2	2014-03-25
Crystalline forms of 1-chloro-4-(.beta.-D-glucopyranos-1-yl)-2-[4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments Grant 8,507,450 - Eckhardt , et al. August 13, 2	2013-08-13
Aryl-and Heteroarylcarbonyl Derivatives Of Hexahydroindenopyridine And Octahydrobenzoquinoline App 20120157488 - Eckhardt; Matthias ; et al.	2012-06-21
Cyclic Inhibitors Of 11beta-hydroxysteroid Dehydrogenase 1 App 20120108579 - Renz; Martin ; et al.	2012-05-03
Cyclic Inhibitors Of 11beta-hydroxysteroid Dehydrogenase 1 App 20100331320 - Renz; Martin ; et al.	2010-12-30
Crystalline forms of 1-chloro-4-(.beta.-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy- )-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments Grant 7,723,309 - Himmelsbach , et al. May 25, 2	2010-05-25
Crystalline form of 1-chloro-4-(.beta.-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy- )-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments Grant 7,713,938 - Himmelsbach , et al. May 11, 2	2010-05-11
Crystalline Form Of 1-choloro-4-(beta-d-glucopyranos-1-yl)-2-[4-((s)-tetrahydrofuran-3-yloxy)- -benzyl]-benzene, A Method For Its Preparation And The Use Thereof For Preparing Medicaments App 20100099641 - HIMMELSBACH; Frank ; et al.	2010-04-22
Crystalline form of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-- benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments App 20070249544 - Himmelsbach; Frank ; et al.	2007-10-25
Crystalline forms of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-[4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments App 20070054867 - Eckhardt; Matthias ; et al.	2007-03-08
Crystalline forms of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-- benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments App 20060251728 - Himmelsbach; Frank ; et al.	2006-11-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.